Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 2000, p. 2546-2549, Vol. 38, No. 7
Division of Comparative Medicine,
Massachusetts Institute of Technology,
Cambridge,1 and Forsyth Institute,
Boston,2 Massachusetts, and National
Laboratory for Enteric Pathogens, Winnipeg,
Canada3
Received 18 February 2000/Returned for modification 28 March
2000/Accepted 11 April 2000
We recently analyzed 11 helicobacter isolates cultured from
diarrhea patients in Canada. These isolates had been characterized biochemically by restriction fragment length polymorphism (RFLP; AluI, HhaI) analysis and by fatty-acid analysis
as Helicobacter pullorum. However, four of the isolates
differed biochemically from H. pullorum by their
inability to hydrolyze indoxyl acetate and their resistance to
nalidixic acid. Using complete 16S rRNA analysis, we determined that
these four strains clustered near H. pullorum but had
a sequence difference of 2% and therefore represent a novel
helicobacter, Helicobacter canadensis. This novel
helicobacter could also be distinguished from H. pullorum by RFLP analysis using ApaLI. The number of
novel Helicobacter spp. associated with gastrointestinal
disease in humans and animals is rapidly increasing. There are now six
Helicobacter spp. isolated from diarrheic humans, the other
five being H. pullorum, H. canis, "H. rappini," H. fennelliae, and
H. cinaedi. This finding highlights the importance of
careful molecular analysis in addition to standard biochemical tests in
identifying the increasing number of Helicobacter spp.
isolated from humans and animals.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Helicobacter canadensis sp. nov.
Isolated from Humans with Diarrhea as an Example of an Emerging
Pathogen
*
Corresponding author. Mailing address: Division of
Comparative Medicine, Massachusetts Institute of Technology, 77 Massachusetts Ave., Bldg. 16, Rm. 825C, Cambridge, MA 02139. Phone:
(617) 253-1757. Fax: (617) 258-5708. E-mail: jgfox{at}mit.edu.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|